Regioselective Glucuronidation of Andrographolide and Its Major Derivatives: Metabolite Identification, Isozyme Contribution, and Species Differences
暂无分享,去创建一个
Guangbo Ge | Ling Yang | Xiaochi Ma | Xiangge Tian | Chao Wang | Kexin Liu | Baojian Wu | S. Liang | S. Deng
[1] Y. Sai,et al. Determination of six components of Andrographis paniculata extract and one major metabolite of andrographolide in rat plasma by liquid chromatography-tandem mass spectrometry. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[2] J. Brockmöller,et al. Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review. , 2014, Pharmacology & therapeutics.
[3] Guangbo Ge,et al. A highly selective probe for human cytochrome P450 3A4: isoform selectivity, kinetic characterization and its applications. , 2013, Chemical communications.
[4] Yitao Wang,et al. Comparative metabolism and stability of andrographolide in liver microsomes from humans, dogs and rats using ultra-performance liquid chromatography coupled with triple-quadrupole and Fourier transform ion cyclotron resonance mass spectrometry. , 2013, Rapid communications in mass spectrometry : RCM.
[5] Guangbo Ge,et al. The Inhibitory Effect of 20(S)‐Protopanaxatriol (ppt) Towards UGT1A1 and UGT2B7 , 2013, Phytotherapy research : PTR.
[6] Junsong Wang,et al. Quantitative analysis of four major diterpenoids in Andrographis paniculata by 1H NMR and its application for quality control of commercial preparations. , 2012, Journal of pharmaceutical and biomedical analysis.
[7] Nutan,et al. Anti-HIV activity of semisynthetic derivatives of andrographolide and computational study of HIV-1 gp120 protein binding. , 2012, European journal of medicinal chemistry.
[8] X. Yao,et al. Two novel creatinine adducts of andrographolide in human urine , 2012, Xenobiotica; the fate of foreign compounds in biological systems.
[9] J. Miners,et al. The glycosidation of xenobiotics and endogenous compounds: versatility and redundancy in the UDP glycosyltransferase superfamily. , 2012, Pharmacology & therapeutics.
[10] M. Finel,et al. Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms , 2012, Drug Metabolism and Disposition.
[11] Bao-jing Zhang,et al. Microbial transformation of deoxyandrographolide and their inhibitory activity on LPS-induced NO production in RAW 264.7 macrophages. , 2012, Bioorganic & medicinal chemistry letters.
[12] Hong-min Liu,et al. Anti-inflammatory effect of novel andrographolide derivatives through inhibition of NO and PGE2 production. , 2011, International immunopharmacology.
[13] S. Basu,et al. First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics. , 2011, Journal of pharmaceutical sciences.
[14] Wei Liu,et al. Species and Gender Differences Affect the Metabolism of Emodin via Glucuronidation , 2010, The AAPS Journal.
[15] Wei Liu,et al. Use of Isoform-Specific UGT Metabolism to Determine and Describe Rates and Profiles of Glucuronidation of Wogonin and Oroxylin A by Human Liver and Intestinal Microsomes , 2010, Pharmaceutical Research.
[16] Zheng-Tao Wang,et al. Identification of the UDP-Glucuronosyltransferase Isozyme Involved in Senecionine Glucuronidation in Human Liver Microsomes , 2010, Drug Metabolism and Disposition.
[17] S. Kerr,et al. Identification of Human UGT2B7 as the Major Isoform Involved in the O-Glucuronidation of Chloramphenicol , 2010, Drug Metabolism and Disposition.
[18] K. Knights,et al. Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators , 2010, Drug metabolism reviews.
[19] Yasuhiro Aoki,et al. Quantitative Analysis of UDP-Glucuronosyltransferase (UGT) 1A and UGT2B Expression Levels in Human Livers , 2009, Drug Metabolism and Disposition.
[20] N. Trivedi,et al. Potency of Andrographolide as an Antitumor Compound in BHC-Induced Liver Damage , 2009, Integrative cancer therapies.
[21] Qipeng Yuan,et al. Microbial transformation of dehydroandrographolide by Cunninghamella elegans , 2009, Journal of Asian natural products research.
[22] Z. Cai,et al. Identification of four urea adducts of andrographolide in humans. , 2008, Drug metabolism letters.
[23] S. Nagar,et al. Resveratrol (trans-Resveratrol, 3,5,4′-Trihydroxy-trans-stilbene) Glucuronidation Exhibits Atypical Enzyme Kinetics in Various Protein Sources , 2008, Drug Metabolism and Disposition.
[24] Huibin Zhang,et al. Synthesis of andrographolide derivatives and their TNF-alpha and IL-6 expression inhibitory activities. , 2007, Bioorganic & medicinal chemistry letters.
[25] M. Stevens,et al. Semisynthesis and in vitro anticancer activities of andrographolide analogues. , 2007, Phytochemistry.
[26] C. Guillemette,et al. The Impact of UGT1A8, UGT1A9, and UGT2B7 Genetic Polymorphisms on the Pharmacokinetic Profile of Mycophenolic Acid After a Single Oral Dose in Healthy Volunteers , 2007, Clinical pharmacology and therapeutics.
[27] J. Satayavivad,et al. Inhibitory effect of Andrographis paniculata extract and its active diterpenoids on platelet aggregation. , 2006, European journal of pharmacology.
[28] J. Miners,et al. SELECTIVITY OF SUBSTRATE (TRIFLUOPERAZINE) AND INHIBITOR (AMITRIPTYLINE, ANDROSTERONE, CANRENOIC ACID, HECOGENIN, PHENYLBUTAZONE, QUINIDINE, QUININE, AND SULFINPYRAZONE) “PROBES” FOR HUMAN UDP-GLUCURONOSYLTRANSFERASES , 2006, Drug Metabolism and Disposition.
[29] Y. Yang,et al. Chin. Tradit. Herb. Drugs. , 2006 .
[30] R. Foti,et al. ALTERED AZT (3′-AZIDO-3′-DEOXYTHYMIDINE) GLUCURONIDATION KINETICS IN LIVER MICROSOMES AS AN EXPLANATION FOR UNDERPREDICTION OF IN VIVO CLEARANCE: COMPARISON TO HEPATOCYTES AND EFFECT OF INCUBATION ENVIRONMENT , 2005, Drug Metabolism and Disposition.
[31] X. Yao,et al. ISOLATION AND IDENTIFICATION OF SEVEN GLUCURONIDE CONJUGATES OF ANDROGRAPHOLIDE IN HUMAN URINE , 2005, Drug Metabolism and Disposition.
[32] X. Yao,et al. Four new andrographolide metabolites in human urine. , 2004, Chemical & pharmaceutical bulletin.
[33] Juei-Tang Cheng,et al. Antihyperglycemic effect of andrographolide in streptozotocin-induced diabetic rats. , 2003, Planta medica.
[34] D. Greenblatt,et al. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[35] J. Ritter. Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. , 2000, Chemico-biological interactions.
[36] H. Wagner,et al. Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[37] R. Tukey,et al. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. , 2000, Annual review of pharmacology and toxicology.
[38] T. Tephly,et al. Human UGT2B7 catalyzes morphine glucuronidation. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[39] B. Shukla,et al. Choleretic effect of andrographolide in rats and guinea pigs. , 1992, Planta medica.